2BB score and signals
Organogenesis’s current 2BB score is 50 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 50 | Moderate |
| Momentum | 71 | Improving |
| Financial strength | 56 | Normal |
| Quality | 100 | Very Strong |
| Risk | 42 | Moderate |
Company facts
| CEO | Gary S. Gillheeney Sr. |
| Headquarters | Canton, Massachusetts, United States |
| Employees | 854 |
| 52-week range | $1.54 – $7.08 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | -0.0571 | — | $64.26M |
| 2026-11-04 | — | -0.1785 | — | $53.14M |
| 2026-08-06 | — | -0.357 | — | $55.34M |
Related companies
